Abeona Therapeutics (ABEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2017 | 03-2017 | 12-2016 | 09-2016 | 06-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -13,526 | -5,247 | -21,873 | -14,871 | -12,247 |
| Depreciation Amortization | 457 | 250 | 825 | 577 | 355 |
| Accounts receivable | 27 | -24 | -9 | -491 | 3 |
| Other Working Capital | -1,064 | -2,714 | 2,364 | 250 | 995 |
| Other Operating Activity | 3,267 | 1,878 | 5,679 | 4,914 | 5,262 |
| Operating Cash Flow | $-10,839 | $-5,857 | $-13,014 | $-9,621 | $-5,632 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -84 | -74 | -519 | -501 | -353 |
| Investing Cash Flow | $-84 | $-74 | $-519 | $-501 | $-353 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 85 | 1 | 42,387 | 1,169 | 150 |
| Common Stock Repurchased | N/A | N/A | 150 | N/A | N/A |
| Financing Cash Flow | $85 | $1 | $42,537 | $1,169 | $150 |
| Beginning Cash Position | 69,142 | 69,142 | 40,138 | 40,138 | 40,138 |
| End Cash Position | 58,304 | 63,212 | 69,142 | 31,185 | 34,303 |
| Net Cash Flow | $-10,838 | $-5,930 | $29,004 | $-8,953 | $-5,835 |
| Free Cash Flow | |||||
| Operating Cash Flow | -10,839 | -5,857 | -13,014 | -9,621 | -5,632 |
| Capital Expenditure | -84 | -74 | -519 | -501 | -353 |
| Free Cash Flow | -10,923 | -5,931 | -13,533 | -10,122 | -5,985 |